No Benefit of High Dose Methotrexate (HD-MTX) in Intermediate Risk Childhood Acute Lymphoblastic Leukemia (ALL): Results of 2 Randomised Multicenter Trials in Russia

被引：0
|
作者：
Karachunskiy, A. [1 ]
Ponomareva, N. [2 ]
Roumiantseva, J. [1 ]
Aleynikova, O. [3 ]
Arakaev, O. [4 ]
Litvinov, D. [1 ]
Karelin, A. [1 ]
Boychenko, E. [5 ]
Sharapova, G. [6 ]
Lagoyko, S. [1 ]
Bydanov, O. [3 ]
Henze, G. [7 ]
机构：
[1] Fed Res Ctr Paediat Haematol Oncol & Immunol, Inst Oncol Radiol & Nucl Med, Moscow, Russia
[2] Russian Childrens Clin Hosp, Dept Haematol, Moscow, Russia
[3] Republ Clin Res Ctr Paediat Haematol Oncol & Immu, Dept Haematol Oncol, Minsk, BELARUS
[4] Reg Childrens Hosp, Paediat Oncohematol Ctr, Ekaterinburg, Russia
[5] St Petersburg Municipal Children Hosp 1, Dept Haematol, St Petersburg, Russia
[6] Reg Childrens Clin Hosp, Dept Haematol, Nizhnevartovsk, Russia
[7] Charite Univ Med Berlin, Dept Paediat Oncol Haematol, Berlin, Germany
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-089
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETIC OF HIGH DOSE METHOTREXATE (HD-MTX) TREATMENTS IN CHILDHOOD LEUKEMIA
    Kovacs, Gabor
    Csordas, Katalin
    Csoka, Monika
    Hegyi, Marta
    Eipel, Oliver
    Muller, Judit
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 762 - 762
  • [2] ETHNIC-SPECIFIC PREDICTORS OF NEUROTOXICITY AMONG PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS FOLLOWING HIGH-DOSE METHOTREXATE (HD-MTX): A REDUCING ETHNIC DISPARITIES IN ACUTE LEUKEMIA (REDIAL) CONSORTIUM REPORT
    Harris, Rachel
    Zobeck, Mark
    Bernhardt, Melanie
    Rabin, Karen
    Schafer, Eric
    Hsiao, Heidi
    Taylor, Olga
    Lupo, Philip
    Scheurer, Michael
    Brown, Austin
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S353 - S353
  • [3] INFECTIONS DURING HIGH DOSE METHOTREXATE THERAPY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Mosleh, T.
    Islam, A.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S256 - S256
  • [4] Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia
    Dordelmann, M
    Reiter, A
    Zimmermann, M
    Fengler, R
    Henze, G
    Riehm, H
    Schrappe, M
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1998, 20 (05) : 444 - 450
  • [5] INTERMEDIATE DOSE METHOTREXATE (IDM) FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A FOLLOW-UP REPORT
    GREEN, DM
    BRECHER, ML
    GROSSI, M
    WANG, JJ
    SINKS, LF
    FREEMAN, AI
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 123 - 123
  • [6] Comparison of high-dose methotrexate (HD-MTX) with Capizzi methotrexate plus asparaginase (C-MTX/ASNase) in children and young adults with high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children's Oncology Group Study AALL0232
    Larsen, E. C.
    Salzer, W. L.
    Devidas, M.
    Nachman, J. B.
    Raetz, E. A.
    Loh, M. L.
    Heerema, N. A.
    Carroll, A. J.
    Gastier-Foster, J. M.
    Borowitz, M. J.
    Wood, B. L.
    Willman, C. L.
    Winick, N. J.
    Hunger, S.
    Carroll, W. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)
  • [7] NO DIFFERENCE IN EFS AND OS AFTER HIGH VERSUS LOW DOSE METHOTREXATE DURING CONSOLIDATION TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN INTERMEDIATE RISK PATIENTS: RESULTS OF RANDOMISED MB 2002 STUDY
    Karachunskiy, Alexandr
    Roumiantseva, Julia
    Lagoiko, Svetlana
    Alejnikova, Olga
    Litvinov, Dimitry
    Ponomareva, Natalia
    Kondratchik, Konstantin
    Shamardina, Anastasia
    Abugova, Julia
    Mansurova, Ekaterina
    Judina, Natalia
    Streneva, Olga
    von Stackelberg, Arend
    Rumyantsev, Alexandr
    Henze, Guenter
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1004 - 1005
  • [8] Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma
    Takaaki Nakano
    Ryoji Kobayashi
    Satoru Matsushima
    Daiki Hori
    Masato Yanagi
    Daisuke Suzuki
    Kunihiko Kobayashi
    International Journal of Hematology, 2021, 113 : 744 - 750
  • [9] Effect of High-Dose Methotrexate (HD-MTX) Vs Capizzi Methotrexate/Pegaspargase (C-MTX/ASNase) on Osteonecrosis (ON) Incidence in Children and Young Adults with T-Acute Lymphoblastic Leukemia (T-ALL): Results of Children's Oncology Group (COG) Study AALL0434
    Mattano, Leonard A.
    Devidas, Meenakshi
    Chen, Si
    Esiashvili, Natia
    Asselin, Barbara
    Winick, Naomi J.
    Loh, Mignon
    Raetz, Elizabeth A.
    Hunger, Stephen
    Carroll, William L.
    Winter, Stuart S.
    Dunsmore, Kimberly P.
    BLOOD, 2014, 124 (21)
  • [10] Risk Factors of Delayed Elimination of High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia or Lymphoma
    Nakano, Takaaki
    Kobayashi, Ryouji
    Matsushima, Satoru
    Hori, Daiki
    Yanagi, Masato
    Suzuki, Daisuke
    Kobayashi, Kunihiko
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S29 - S29
12345